文献速递甲状腺与浅表US

应用超声风险分层系统提升甲状腺细针穿刺活检的表现

Using an ultrasonography risk stratification system to enhance the thyroid fine needle aspiration performance.
PubMed 文献 · Eur J Radiol · 2022-03-10

该单中心回顾性研究纳入2012至2019年接受细针穿刺活检的938例患者共1044个甲状腺结节,评估ACR TI-RADS对活检推荐及诊断表现的影响。按TI-RADS标准仅314个(30%)结节需行FNAB,其中51个(16.2%)为Bethesda V或VI;未达活检标准的729个结节中17个(2.3%)为Bethesda V或VI,7例恶性病例被漏诊(0.9%)。结论认为ACR TI-RADS可显著减少FNAB数量并提高诊断准确性。

要点

  • 按ACR TI-RADS标准仅30%(314/1044)结节需行FNAB。
  • TI-RADS分类敏感度75%、阴性预测值97.6%、准确率73.1%。
  • 未达FNAB标准的729个结节中17个(2.3%)为Bethesda V或VI。

核心结论

  • ACR TI-RADS可显著减少FNAB数量并提高其诊断准确性。

研究设计与样本

  • 单中心回顾性研究,纳入2012至2019年接受FNAB的938例患者共1044个甲状腺结节,从病历提取TI-RADS数据,以细胞学检查定义恶性率。

诊断标准与关键数值

  • TI-RADS分类:TI-RADS 1共13个、TI-RADS 2共524个、TI-RADS 3共273个、TI-RADS 4共148个、TI-RADS 5共85个;敏感度75%(95%CI 63-84.7)、阴性预测值97.6%(95%CI 96.5-98.5)、准确率73.1%(95%CI 70.3-75.8)。

临床应用与阅片要点

  • 按TI-RADS FNAB标准仅314个(30%)结节需行FNAB,其中157个(50%)为Bethesda II、45个(14.3%)为Bethesda III或IV、51个(16.2%)为Bethesda V或VI。

局限性

  • 原文为单中心回顾性研究。
  • 未达FNAB标准的729个结节中17个(2.3%)为Bethesda V或VI,其中4个(23%)小于1 cm为微小癌。
  • 7例恶性病例被漏诊(0.9%)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOUSE: The American College of Radiology Thyroid Imaging Reporting and Data System (ACR TI-RADS) is a risk stratification system for thyroid nodules based on their ultrasonography (US) characteristics. Here, we aimed to assess TI-RADS on fine needle aspiration biopsy (FNAB) recommendations and performance in thyroid nodules.

METHODS: We performed a retrospective study in a single center. All patients with thyroid nodules who underwent FNAB between 2012 and 2019 were included. TI-RADS data were extracted from medical records. Malignancy rates were defined based on cytological exams.

RESULTS: A total of 1,044 nodules (938 patients) were evaluated. TI-RADS classification was as follows: 13 TI-RADS 1, 524 TI-RADS 2, 273 TI-RADS 3, 148 TI-RADS 4, and 85 TI-RADS 5. TI-RADS classification showed a sensitivity of 75% (95 %CI: 63-84.7), a negative predictive value of 97.6% (95 %CI: 96.5-98.5), and accuracy of 73.1% (95 %CI: 70.3-75.8). According to TI-RADS FNAB criteria, only 314 (30%) nodules would have undergone FNAB. Of them, 157 (50%) were classified as benign (Bethesda II), 45 (14.3%) as undetermined (Bethesda III or IV), and 51 (16.2%) as malignant (Bethesda V or VI). Of the remaining 729 nodules that did not meet FNAB criteria, 17 (2.3%) had Bethesda V or VI and underwent surgery. Of them, four (23%) were <1 cm in size (microcarcinomas), and eight (47.0%) remain in follow-up according to the TI-RADS criteria. Seven malignant cases would be missed (0.9%).

CONCLUSION: ACR TI-RADS allows a significant decrease in the number of FNAB, increasing its diagnostic accuracy.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Strieder, Cristo, Zanella, et al. Using an ultrasonography risk stratification system to enhance the thyroid fine needle aspiration performance. Eur J Radiol. 2022. PMID: 35299112. doi:10.1016/j.ejrad.2022.110244

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。